<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="weaver" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">weaver</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">EZH2</italic>-Related Overgrowth</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tatton-Brown</surname>
            <given-names>Katrina</given-names>
          </name>
          <degrees>BMBCh, MD</degrees>
          <email>kate.tatton-brown@icr.ac.uk</email>
          <aff>Consultant and Honorary Senior Lecturer in Clinical Genetics<break/>St George&#x02019;s University of London<break/>Institute of Cancer Research<break/>Sutton, Surrey, United Kingdom</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rahman</surname>
            <given-names>Nazneen</given-names>
          </name>
          <degrees>BMBCh, PhD</degrees>
          <aff>Professor of Human Genetics<break/>Institute of Cancer Research<break/>Sutton, Surrey, United Kingdom</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2013-07-18" date-type="created">
          <day>18</day>
          <month>7</month>
          <year>2013</year>
        </date>
        <date iso-8601-date="2015-08-06" date-type="updated">
          <day>6</day>
          <month>8</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="exosc3-pc-hypo-p" document-type="chapter"><italic toggle="yes">EXOSC3</italic>-Related Pontocerebellar Hypoplasia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="alzheimer-early" document-type="chapter">Early-Onset Familial Alzheimer Disease</related-object>
      <abstract id="weaver.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">EZH2-</italic>related overgrowth includes <italic toggle="yes">EZH2-</italic>related Weaver syndrome at one end of the spectrum and tall stature at the other. Although most individuals diagnosed with a heterozygous <italic toggle="yes">EZH2</italic> pathogenic variant have been identified because of a clinical suspicion of Weaver syndrome, a minority have been identified through molecular genetic testing of family members of probands or individuals with overgrowth who did not have a clinical diagnosis of Weaver syndrome. Thus, the extent of the phenotypic spectrum associated with a heterozygous <italic toggle="yes">EZH2</italic> pathogenic variant is not yet known.</p>
          <p>Weaver syndrome is characterized by tall stature, variable intellect (ranging from normal intellect to severe intellectual disability), characteristic facial appearance, and a range of associated clinical features including advanced bone age, poor coordination, soft doughy skin, camptodactyly of the fingers or toes, umbilical hernia, abnormal tone, and hoarse low cry in infancy. Neuronal migration disorders have also been reported in a few individuals with <italic toggle="yes">EZH2-</italic>related overgrowth. Neuroblastoma occurs at a slightly increased frequency in individuals with a heterozygous <italic toggle="yes">EZH2</italic> pathogenic variant but data are insufficient to determine absolute risk. There is currently no evidence that additional malignancies (including hematologic malignancies) occur with increased frequency.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">EZH2-</italic>related overgrowth is based on detection of a heterozygous germline <italic toggle="yes">EZH2</italic> pathogenic variant on molecular genetic testing<italic toggle="yes">.</italic></p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> For individuals with developmental delay and/or learning disability, referral for learning/behavior/speech assessment and support may be indicated. Occasionally, toe camptodactyly may require surgical intervention. Physiotherapy may be of benefit to those experiencing joint pain secondary to ligamentous laxity or joint contractures. Treatment of scoliosis is routine. The appropriate specialist referral(s) should be made for other clinical issues.</p>
          <p><italic toggle="yes">Surveillance:</italic> Regular medical follow up of young children with <italic toggle="yes">EZH2-</italic>related Weaver syndrome to monitor developmental progress, camptodactyly (for resolution/improvement), and/or hypotonia; medical follow up of older children/teenagers who do not have medical complications may be less frequent. If scoliosis is present, monitoring as per the orthopedic recommendations. Although current data do not support specific tumor surveillance programs, clinicians should have a low threshold for investigating any findings that may be tumor (particularly neuroblastoma) related.</p>
          <p><italic toggle="yes">Pregnancy management:</italic> Families and their health care providers should be aware that an affected baby may be large so that appropriate delivery plans can be made.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">EZH2-</italic>related overgrowth is inherited in an autosomal dominant manner; a <italic toggle="yes">de novo</italic> germline pathogenic variant may be common. Each child of an individual with an <italic toggle="yes">EZH2</italic> pathogenic variant has a 50% chance of inheriting the pathogenic variant; the phenotype of an individual inheriting the <italic toggle="yes">EZH2</italic> pathogenic variant cannot be predicted. If the pathogenic variant has been identified in an affected family member, prenatal diagnosis for pregnancies at increased risk is possible.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="weaver.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="weaver.Tc" position="anchor" orientation="portrait">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_weaver.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">EZH2</italic>-Related Overgrowth: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_weaver.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p><italic toggle="yes">EZH2</italic>-related Weaver syndrome</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="weaver.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="weaver.Diagnosis">
        <title>Diagnosis</title>
        <sec id="weaver.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><italic toggle="yes">EZH2</italic>-related overgrowth <bold>should be suspected</bold> in an individual with the following clinical and radiographic findings [<xref ref-type="bibr" rid="weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</xref>]:</p>
          <p>
            <bold>Clinical findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Tall stature (height &#x02265;+2 SD)</p>
            </list-item>
            <list-item>
              <p>Macrocephaly (head circumference &#x02265;+2 SD)</p>
            </list-item>
            <list-item>
              <p>Intellectual disability</p>
            </list-item>
            <list-item>
              <p>Characteristic facial appearance</p>
              <list list-type="bullet">
                <list-item>
                  <p>In children younger than age three years: retrognathia, large and fleshy ears, and a &#x0201c;stuck on&#x0201d; appearance to the chin associated with a horizontal skin crease and sometimes a central dimple</p>
                </list-item>
                <list-item>
                  <p>In affected individuals of all ages, additional features including (<xref ref-type="fig" rid="weaver.F1">Figure 1</xref>):</p>
                  <list list-type="bullet">
                    <list-item>
                      <p>Broad forehead</p>
                    </list-item>
                    <list-item>
                      <p>Widely spaced eyes</p>
                    </list-item>
                    <list-item>
                      <p>Almond-shaped palpebral fissures</p>
                    </list-item>
                    <list-item>
                      <p>Round face, particularly in younger childhood</p>
                    </list-item>
                  </list>
                </list-item>
                <list-item>
                  <p>Poor coordination</p>
                </list-item>
                <list-item>
                  <p>Soft and doughy skin</p>
                </list-item>
                <list-item>
                  <p>Camptodactyly of the fingers and/or toes</p>
                </list-item>
                <list-item>
                  <p>Umbilical hernia</p>
                </list-item>
                <list-item>
                  <p>Abnormal tone (central hypotonia and/or peripheral hypertonia)</p>
                </list-item>
                <list-item>
                  <p>Hoarse, low-pitched cry (sometimes described as quiet)</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Radiographic findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Advanced bone age on plain radiographs</p>
            </list-item>
            <list-item>
              <p>Neuronal migration disorder (rare) on head MRI</p>
            </list-item>
          </list>
        </sec>
        <sec id="weaver.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of <italic toggle="yes">EZH2-</italic>related overgrowth <bold>is established</bold> in a proband by detection of a heterozygous germline <italic toggle="yes">EZH2</italic> pathogenic variant on molecular genetic testing (see <xref ref-type="table" rid="weaver.T.molecular_genetic_testing_used">Table 1</xref>)<italic toggle="yes">.</italic></p>
          <p>Note: Although not all individuals with suspected Weaver syndrome are shown to have an <italic toggle="yes">EZH2</italic> pathogenic variant (see <xref ref-type="sec" rid="weaver.Differential_Diagnosis">Differential Diagnosis</xref>) it is difficult to quantify the detection rate given that some affected individuals present with tall stature and no additional clinical features.</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold> and use of a <bold>multi-gene panel.</bold></p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">EZH2</italic> is performed first. Current data do not support <italic toggle="yes">EZH2</italic> dosage abnormalities as a cause of <italic toggle="yes">EZH2</italic>-related Weaver syndrome/overgrowth; thus, the role of gene-targeted deletion/duplication analysis is currently unclear.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">EZH2</italic> and other genes of interest (see <xref ref-type="sec" rid="weaver.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and sensitivity of multi-gene panels vary by laboratory and over time.</p>
            </list-item>
          </list>
          <table-wrap id="weaver.T.molecular_genetic_testing_used" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in <italic toggle="yes">EZH2-</italic>Related Overgrowth</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">EZH2</italic>
                  </td>
                  <td headers="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">See footnote 4</td>
                </tr>
                <tr>
                  <td headers="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_weaver.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup>, none reported</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="weaver.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="weaver" object-id="weaver.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="weaver.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="weaver.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="weaver.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="weaver.TF.1.4">
                <label>4. </label>
                <p>To date 52 individuals with an <italic toggle="yes">EZH2</italic> germline pathogenic variant have been reported [<xref ref-type="bibr" rid="weaver.REF.tattonbrown.2011.1127">Tatton-Brown et al 2011</xref>, <xref ref-type="bibr" rid="weaver.REF.gibson.2012.110">Gibson et al 2012</xref>, <xref ref-type="bibr" rid="weaver.REF.alsalem.2013.225">Al-Salem et al 2013</xref>, <xref ref-type="bibr" rid="weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</xref>].</p>
              </fn>
              <fn id="weaver.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="weaver.TF.1.6">
                <label>6. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="weaver.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="weaver.Clinical_Description">
          <title>Clinical Description</title>
          <p>The phenotypic spectrum associated with constitutional <italic toggle="yes">EZH2</italic> pathogenic variants is broad with classic Weaver syndrome at one end of the spectrum and tall stature at the other. Although most individuals diagnosed with a heterozygous germline <italic toggle="yes">EZH2</italic> pathogenic variant have been identified because of a clinical suspicion of Weaver syndrome, a minority have been identified through molecular genetic testing of family members of probands or individuals with overgrowth who did not have a clinical diagnosis of Weaver syndrome [<xref ref-type="bibr" rid="weaver.REF.tattonbrown.2011.1127">Tatton-Brown et al 2011</xref>, <xref ref-type="bibr" rid="weaver.REF.gibson.2012.110">Gibson et al 2012</xref>]. Thus, the extent of the phenotypic spectrum of heterozygous <italic toggle="yes">EZH2</italic> pathogenic variants is not yet known. Findings in 48 individuals with Weaver syndrome and a heterozygous <italic toggle="yes">EZH2</italic> pathogenic variant are summarized below [<xref ref-type="bibr" rid="weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</xref>].</p>
          <p>Note: The different denominators quoted reflect the numbers of individuals for whom the particular phenotypic data were provided.</p>
          <p><bold>Growth.</bold> From data available on 18 newborns, the median birth length was 2.1 standard deviations above the mean (+2.1 SD) with a range of -0.5 SD to +4.9 SD; the median birth weight of 39 newborns was +1.3 SD with a range of -1.6 SD to +4.6 SD.</p>
          <p>Tall stature is a near-consistent finding: 41/45 individuals (on whom information about height was available) had a height at least two standard deviations above the mean (ages 1-70 years). Of note, three of the four individuals with a height lower than +2 SD had been tall as young children.</p>
          <p>Of 40 individuals on whom information was available, 21 had a head circumference lower than +2 SD and 19 had macrocephaly with a head circumference ranging up to +5.5 SD and 21 had a head circumference lower than +2 SD.</p>
          <p><bold>Cognitive features.</bold> Variable intellectual disability (ID) was observed in 37 of 45 individuals including the following (normal intellect was observed in 8 of 45 individuals):</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Mild ID</bold> (21/37) (i.e., children attend mainstream school and need some extra help &#x02013; e.g., a statement of educational needs &#x02013; but would be expected to live independently as adults and would be likely to have their own family)</p>
            </list-item>
            <list-item>
              <p><bold>Moderate ID</bold> (12/37) (i.e., children develop speech and need a high level of support in mainstream education but more likely will attend a school catering for special educational needs. While unlikely to live independently as adults, they may live in sheltered accommodation or with some additional support.)</p>
            </list-item>
            <list-item>
              <p><bold>Severe ID</bold> (2/37) (i.e., individuals who require special education needs schooling and who are likely to require considerable support in adulthood)</p>
            </list-item>
            <list-item>
              <p><bold>Unclassified ID</bold> (2/37) (i.e., insufficient information provided to make a determination)</p>
            </list-item>
          </list>
          <p><bold>Facial features.</bold> The characteristic facial appearance evolves over time (see <xref ref-type="sec" rid="weaver.Suggestive_Findings">Suggestive Findings</xref> and <xref ref-type="fig" rid="weaver.F1">Figure 1</xref>) although it is most distinctive at a younger age; therefore, review of younger childhood photographs may help the clinician reach a clinical diagnosis.</p>
          <p>
            <bold>Skeletal features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Advanced bone age.</bold> Of 25 individuals evaluated, all had an advanced bone age.</p>
            </list-item>
            <list-item>
              <p><bold>Scoliosis</bold> was reported in 6/44 and pectus excavatum in 3/44 individuals. Scoliosis ranged from severe (early-childhood onset requiring surgical intervention) to mild (requiring monitoring but no therapeutic intervention).</p>
            </list-item>
            <list-item>
              <p><bold>Camptodactyly.</bold> Some affected individuals had camptodactyly of the fingers, some had camptodactyly of the toes, and some had camptodactyly of fingers and toes. On occasion the toe camptodactyly required surgical correction. A detailed past medical history may be necessary to determine if camptodactyly was present in the newborn period/infancy given that it can resolve/improve throughout childhood.</p>
            </list-item>
            <list-item>
              <p><bold>Adult boutonniere deformity.</bold> Several adults developed hyperextension of the distal interphalangeal joints and flexion of the proximal interphalangeal joints of the hands analogous to a mild boutonniere deformity (<xref ref-type="fig" rid="weaver.F2">Figure 2</xref>).</p>
            </list-item>
            <list-item>
              <p><bold>Talipes equinovarus.</bold> Five of 35 individuals had talipes equinovarus ranging from fixed and bilateral requiring surgery in two individuals to mild (unilateral that resolved with physiotherapy) in three.</p>
            </list-item>
          </list>
          <p>
            <bold>Connective tissue</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Skin</bold> that was soft and doughy to the touch was seen in 17/35 affected children.</p>
            </list-item>
            <list-item>
              <p><bold>Ligamentous laxity.</bold> While ligamentous laxity with associated joint hypermobility and pes planus is common, it is not usually reported unless complicated by joint pain. Of note, 28/35 individuals were reported to have poor coordination which may have been (at least partially) attributable to lax ligaments.</p>
            </list-item>
            <list-item>
              <p><bold>Umbilical hernia,</bold> seen in 17/40 children evaluated, was sufficiently large to require surgery in the neonatal period in eight of the 17.</p>
            </list-item>
          </list>
          <p><bold>Abnormal tone.</bold> In general, if abnormal tone (hypotonia, hypertonia, or mixed central hypotonia and peripheral hypertonia) was present this resolved during childhood.</p>
          <list list-type="bullet">
            <list-item>
              <p>Hypotonia (predominantly central) was reported in 18/41 individuals.</p>
            </list-item>
            <list-item>
              <p>Hypertonia (predominantly peripheral manifesting as stiffness in the limbs with brisk reflexes) was reported in 11/39.Note: (1) Three of the individuals presenting with peripheral hypertonia were also reported to have central hypotonia; (2) a detailed past medical history may be necessary to determine if these findings were present in the newborn period/infancy given that they can resolve/improve throughout childhood.</p>
            </list-item>
          </list>
          <p><bold>Poor feeding</bold> was reported in 10/28 neonates including one who required nasogastric tube feeding for two weeks. Although poor feeding may be attributable to neonatal hypotonia, this was only reported in three of the babies with poor feeding.</p>
          <p><bold>Hoarse, low-pitched cry</bold> was reported in in 10/27 affected infants.</p>
          <p><bold>Brain MRI</bold> identified one or more abnormalities in nine individuals (where imaging had been performed). Abnormalities included: ventriculomegaly (in 4); ventriculomegaly and periventricular leukomalacia (1); periventricular leukomalacia (1); persistent cavum septum pellucidum (1); a previous infarct (1); and polymicrogyria and pachygyria (1). Of note, for those with ventriculomegaly for whom data were available, all had normal CSF pressure and none required shunting.</p>
          <p>Intellectual disability in those with a brain MRI abnormality was mild in five; moderate in two who had periventricular leukomalacia (1) and isolated ventriculomegaly (1); and severe in the one with polymicrogyria and pachygyria [<xref ref-type="bibr" rid="weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</xref>].</p>
          <p>Polymicrogyria was also reported in another individual (not part of the current series of 48 individuals in whom <italic toggle="yes">EZH2</italic> pathogenic variants were identified) with the <italic toggle="yes">de novo</italic>
<italic toggle="yes">EZH2</italic> pathogenic variant p.Glu745Lys [<xref ref-type="bibr" rid="weaver.REF.alsalem.2013.225">Al-Salem et al 2013</xref>]. This individual had normal developmental milestones and body asymmetry (left side smaller than the right) with brisk reflexes and increased tone on the left.</p>
          <p><bold>Tumors</bold> were reported in three of 48 affected individuals [<xref ref-type="bibr" rid="weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>One boy with a <xref ref-type="table" rid="weaver.T.ezh2_pathogenic_variants_discus">c.2233G&#x0003e;A</xref> pathogenic variant developed a pre-T cell non-Hodgkins lymphoma at age 13 years. At age 25 years he remains well with no relapses or additional tumors.</p>
            </list-item>
            <list-item>
              <p>One boy with a <xref ref-type="table" rid="weaver.T.ezh2_pathogenic_variants_discus">c.2044G&#x0003e;A</xref> pathogenic variant was diagnosed at age 13 months with acute lymphoblastic leukemia and neuroblastoma, both of which responded to therapy; he is well at age seven years.</p>
            </list-item>
            <list-item>
              <p>One girl with a <xref ref-type="table" rid="weaver.T.ezh2_pathogenic_variants_discus">c.458A&#x0003e;G</xref> pathogenic variant was diagnosed with a neuroblastoma at age four years.</p>
            </list-item>
          </list>
          <p><bold>Additional clinical features</bold> reported in a small number of individuals (and therefore, possibly not associated with the <italic toggle="yes">EZH2</italic> pathogenic variant) are included for completeness:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Cutaneous.</bold> Caf&#x000e9; au lait macules (in 2 individuals), hemangioma (4)</p>
            </list-item>
            <list-item>
              <p><bold>Eye.</bold> Hypermetropia (hyperopia) (3), myopia (1), strabismus (2)</p>
            </list-item>
            <list-item>
              <p><bold>Congenital cardiac anomalies</bold> (2)</p>
            </list-item>
            <list-item>
              <p><bold>Genitourinary.</bold> Cryptorchidism (1), hydrocele (2), hypospadias (1)</p>
            </list-item>
            <list-item>
              <p><bold>Cleft palate</bold> (3)</p>
            </list-item>
            <list-item>
              <p><bold>Gastrointestinal.</bold> Gastroesophageal reflux (1), hiatal hernia (1)</p>
            </list-item>
            <list-item>
              <p><bold>Hearing loss</bold> (3)</p>
            </list-item>
            <list-item>
              <p><bold>Neonatal hypoglycemia</bold> (2)</p>
            </list-item>
            <list-item>
              <p><bold>Afebrile seizures</bold> (2)</p>
            </list-item>
          </list>
        </sec>
        <sec id="weaver.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Findings along the entire phenotypic spectrum have been observed among individuals with heterozygous truncating pathogenic variants or heterozygous missense pathogenic variants, within or outside the conserved SET domain (see <xref ref-type="sec" rid="weaver.Molecular_Genetics">Molecular Genetics</xref>, <bold>Normal gene product</bold>). Thus, among the small number of individuals reported with <italic toggle="yes">EZH2-</italic>related conditions, no specific genotype-phenotype correlations are evident.</p>
        </sec>
        <sec id="weaver.Penetrance">
          <title>Penetrance</title>
          <p>Data are currently insufficient to determine penetrance of <italic toggle="yes">EZH2</italic> germline pathogenic variants. However, given the subtlety of the phenotype in some persons with a likely pathogenic <italic toggle="yes">EZH2</italic> variant, the penetrance for some <italic toggle="yes">EZH2</italic> pathogenic variants may be reduced [<xref ref-type="bibr" rid="weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</xref>].</p>
        </sec>
        <sec id="weaver.Nomenclature">
          <title>Nomenclature</title>
          <p>Weaver syndrome is named after David Weaver, who reported two boys with accelerated osseous maturation, unusual facies, and camptodactyly [<xref ref-type="bibr" rid="weaver.REF.weaver.1974.547">Weaver et al 1974</xref>].</p>
          <p>Pathogenic variants in <italic toggle="yes">NSD1</italic> (the cause of <related-object link-type="booklink" source-id="gene" document-id="sotos" document-type="chapter">Sotos syndrome</related-object>) were once reported to cause Weaver syndrome [<xref ref-type="bibr" rid="weaver.REF.douglas.2003.132">Douglas et al 2003</xref>]. However, this association has been refuted [<xref ref-type="bibr" rid="weaver.REF.tattonbrown.2005.193">Tatton-Brown et al 2005</xref>].</p>
        </sec>
        <sec id="weaver.Prevalence">
          <title>Prevalence</title>
          <p>Because <italic toggle="yes">EZH2</italic> pathogenic variants have only recently been shown to cause Weaver syndrome, and individuals with a mild phenotype may escape clinical diagnosis, it is currently difficult to estimate the prevalence of Weaver syndrome.</p>
        </sec>
      </sec>
      <sec id="weaver.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with germline pathogenic variants in <italic toggle="yes">EZH2</italic>.</p>
      </sec>
      <sec id="weaver.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The following conditions should be considered in the differential diagnosis of Weaver syndrome.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="sotos" document-type="chapter"><bold>Sotos syndrome</bold></related-object><bold>.</bold> The phenotypic overlap between Sotos and Weaver syndromes is considerable: both are characterized by pre- and postnatal overgrowth, variable intellectual disability, and a similar but distinctive facial appearance. The facial appearance in Weaver syndrome is characterized by widely spaced eyes, almond-shaped palpebral fissures and, in infancy, retrognathia and large, fleshy ears. In contrast, the facial appearance in Sotos syndrome is characterized by downslanted palpebral fissures, prominent chin, and malar flushing in children. Advanced bone age and scoliosis have been reported in both conditions. Other clinical features reported in more than 15% of individuals with Sotos syndrome include cardiac anomalies, renal anomalies, and seizures [<xref ref-type="bibr" rid="weaver.REF.tattonbrown.2005.193">Tatton-Brown et al 2005</xref>].</p>
        <p>Sotos syndrome is caused by heterozygous pathogenic variants in <italic toggle="yes">NSD1.</italic> Inheritance is autosomal dominant. More than 95% of individuals have a <italic toggle="yes">de novo</italic> pathogenic variant.</p>
        <p>Although Sotos syndrome and Weaver syndrome were initially reported to be allelic disorders [<xref ref-type="bibr" rid="weaver.REF.douglas.2003.132">Douglas et al 2003</xref>], reevaluation of multiple photographs of the three individuals with an <italic toggle="yes">NSD1</italic> pathogenic variant previously categorized as having Weaver syndrome resulted in reclassification as classic Sotos syndrome (2 individuals) and possible Sotos syndrome (1 individual). Based on these findings, heterozygous <italic toggle="yes">NSD1</italic> pathogenic variants are not believed to cause Weaver syndrome despite the clinical overlap [<xref ref-type="bibr" rid="weaver.REF.douglas.2003.132">Douglas et al 2003</xref>, <xref ref-type="bibr" rid="weaver.REF.tattonbrown.2005.193">Tatton-Brown et al 2005</xref>].</p>
        <p><bold>Malan syndrome</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/614753">614753</ext-link>). Malan syndrome is caused by heterozygous pathogenic variants in <italic toggle="yes">NFIX</italic> and is a Sotos syndrome-like condition associated with tall stature and intellectual disability [<xref ref-type="bibr" rid="weaver.REF.malan.2010.189">Malan et al 2010</xref>, <xref ref-type="bibr" rid="weaver.REF.schanze.2014.1092">Schanze et al 2014</xref>, <xref ref-type="bibr" rid="weaver.REF.klaassens.2015.610">Klaassens et al 2015</xref>]. Whole-gene deletions, usually identified through chromosomal microarray analysis (CMA), have been identified in the majority of individuals to date; however, this may reflect the limited use of diagnostic testing for intragenic <italic toggle="yes">NFIX</italic> pathogenic variants. Inheritance is autosomal dominant.</p>
        <p><bold>DNMT3A overgrowth (Tatton-Brown-Rahman) syndrome</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/615879">615879</ext-link>). Heterozygous pathogenic variants within <italic toggle="yes">DNMT3A</italic>, which encodes a DNA methyltransferase, cause tall stature, a variable but most frequently moderate intellectual disability, and additional features including autistic spectrum disorder, scoliosis, and ligamentous laxity [<xref ref-type="bibr" rid="weaver.REF.tattonbrown.2014.385">Tatton-Brown et al 2014</xref>]. Although characteristic, the facial appearance associated with the DNMT3A overgrowth syndrome is subtle and more easily recognized in the teenage/adult years.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="bws" document-type="chapter"><bold>Beckwith-Wiedemann syndrome</bold></related-object>
<bold>(BWS).</bold> Individuals with both Weaver syndrome and BWS can have tall stature and normal intellect. Umbilical hernia is also reported with increased frequency in both conditions. However, other clinical features characteristic of BWS including macroglossia, ear lobe creases/pits, omphalocele, and visceromegaly are not reported with increased frequency in Weaver syndrome.</p>
        <p>A clinical suspicion of BWS can be confirmed through testing that reveals dysregulation of the normal imprint at the 11p15 growth regulatory region [<xref ref-type="bibr" rid="weaver.REF.choufani.2010.343">Choufani et al 2010</xref>]:</p>
        <list list-type="bullet">
          <list-item>
            <p>Loss of methylation at imprinting center 2 (IC2; see <related-object link-type="booklink" source-id="gene" document-id="bws" document-type="chapter">Beckwith-Wiedeman Syndrome</related-object>, <xref ref-type="fig" rid="weaver.F1">Figure 1</xref> for detailed molecular mechanism) on the maternal allele (in &#x02248;50% of affected individuals)</p>
          </list-item>
          <list-item>
            <p>Uniparental disomy for 11p15 (in &#x02248;20% of affected individuals)</p>
          </list-item>
          <list-item>
            <p>Gain of methylation at imprinting center 1 (IC12; see <related-object link-type="booklink" source-id="gene" document-id="bws" document-type="chapter">Beckwith-Wiedeman Syndrome</related-object>, <xref ref-type="fig" rid="weaver.F1">Figure 1</xref> for detailed molecular mechanism) of the maternal allele (in &#x02248;5% of affected individuals)</p>
          </list-item>
          <list-item>
            <p>Pathogenic variants within the maternal copy of <italic toggle="yes">CDKN1C</italic> (in 5%-10% of sporadic cases of BWS; &#x02264;40% of familial cases)</p>
          </list-item>
        </list>
        <p>In approximately 20% of individuals with a clinical diagnosis of BWS the underlying molecular abnormality is not elucidated.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="sgbs" document-type="chapter"><bold>Simpson-Golabi-Behmel syndrome type 1</bold></related-object>
<bold>(SGBS1)</bold> is an X-linked condition predominantly affecting boys. Whereas both Weaver syndrome and SGBS1 are characterized by overgrowth, SGBS1 can usually be clinically distinguished from Weaver syndrome by the characteristic facial appearance and other features including supernumerary nipples, polydactyly, and diastasis recti [<xref ref-type="bibr" rid="weaver.REF.golabi.1984.345">Golabi &#x00026; Rosen 1984</xref>]. SGBS1 is associated with an increased risk of embryonal tumors, particularly Wilms tumor, and is caused in males by hemizygous pathogenic variants in <italic toggle="yes">GPC3</italic>, and possibly <italic toggle="yes">GPC4</italic>.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="marfan" document-type="chapter"><bold>Marfan syndrome</bold></related-object><bold>.</bold> The skeletal findings in Marfan syndrome can be similar to those of Weaver syndrome (tall stature, scoliosis, and pectus abnormalities); however, individuals with Weaver syndrome do not generally have the ocular (myopia and lens dislocation) or cardiovascular (dilatation of the aorta; mitral and tricuspid valve prolapse) findings of Marfan syndrome [<xref ref-type="bibr" rid="weaver.REF.loeys.2010.476">Loeys et al 2010</xref>]. Additionally, while Weaver syndrome is more commonly associated with intellectual disability, cognitive abilities are usually normal in individuals with Marfan syndrome. Marfan syndrome is caused by heterozygous pathogenic variants in <italic toggle="yes">FBN1</italic>. Inheritance is autosomal dominant.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="cca" document-type="chapter"><bold>Congenital contractural arachnodactyly</bold></related-object>
<bold>(Beals syndrome).</bold> Tall stature and camptodactyly are features of both Weaver syndrome and Beals syndrome, a connective tissue disorder caused by heterozygous pathogenic variants in <italic toggle="yes">FBN2</italic> [<xref ref-type="bibr" rid="weaver.REF.tun_bilek.2006.20">Tun&#x000e7;bilek &#x00026; Alanay 2006</xref>]. Inheritance is autosomal dominant.</p>
      </sec>
      <sec id="weaver.Management_1">
        <title>Management</title>
        <sec id="weaver.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with a heterozygous <italic toggle="yes">EZH2</italic> pathogenic variant, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Developmental assessment</p>
            </list-item>
            <list-item>
              <p>Thorough history to identify clinical features associated with Weaver syndrome</p>
            </list-item>
            <list-item>
              <p>Physical examination with particular attention paid to growth measurements and skeletal findings: camptodactyly (in the newborn period), scoliosis, and pectus deformities. The presence of an abdominal mass warrants immediate investigation.</p>
            </list-item>
            <list-item>
              <p>Consultation with a medical geneticist and/or genetic counselor to identify other family members who could be affected; where possible, measurement of parental heights</p>
            </list-item>
          </list>
        </sec>
        <sec id="weaver.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Educational support.</bold> For individuals with developmental delay and/or learning disability, referral for learning/behavior/speech assessment and support may be indicated.</p>
          <p><bold>Camptodactyly.</bold> Occasionally toe camptodactyly may require surgical intervention. Physiotherapy may also be beneficial.</p>
          <p><bold>Ligamentous laxity.</bold> Physiotherapy may be of some benefit to those individuals experiencing joint pain secondary to ligamentous laxity.</p>
          <p><bold>Scoliosis.</bold> If scoliosis is present a referral to orthopedics for further evaluation and monitoring is appropriate.</p>
          <p>If additional clinical issues are detected through the history and/or examination, the appropriate specialist referral(s) should be made.</p>
        </sec>
        <sec id="weaver.Surveillance">
          <title>Surveillance</title>
          <p>Regular review by a pediatrician is recommended for young children with <italic toggle="yes">EZH2-</italic>related Weaver syndrome to monitor developmental progress, camptodactyly (for resolution/improvement), and/or hypotonia.</p>
          <p>If scoliosis is present, monitor as per the orthopedic recommendations.</p>
          <p>The clinician may wish to review less frequently older children/teenagers who do not have medical complications.</p>
          <p>Current data suggest that there may be a slightly increased relative risk for the development of neuroblastoma in individuals with heterozygous germline <italic toggle="yes">EZH2</italic> pathogenic variants. Although the numbers are too small to quantify the absolute tumor risk, it appears to be low. In addition, given that neuroblastoma surveillance has been inconsistent with no data to support the modality of surveillance, screening interval or duration, the current recommendations include clinical vigilance and thorough investigation of any symptoms that may be tumor related.</p>
        </sec>
        <sec id="weaver.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="weaver.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="weaver.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>In general, pregnancies in which the mother and/or fetus has a heterozygous <italic toggle="yes">EZH2</italic> pathogenic variant are uncomplicated. Families and their health care providers should be aware that an affected baby may be large so that appropriate delivery plans can be made; in addition, information about the <italic toggle="yes">EZH2-</italic>related overgrowth phenotype should be provided.</p>
        </sec>
        <sec id="weaver.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="weaver.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="weaver.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">EZH2-</italic>related overgrowth is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="weaver.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Some individuals diagnosed with <italic toggle="yes">EZH2-</italic>related overgrowth have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with <italic toggle="yes">EZH2</italic>-related overgrowth may have the disorder as the result of a <italic toggle="yes">de novo EZH2</italic> pathogenic variant. The proportion of <italic toggle="yes">EZH2-</italic>related overgrowth caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown. In the series of 48 individuals identified with an <italic toggle="yes">EZH2</italic> pathogenic variant [<xref ref-type="bibr" rid="weaver.REF.tattonbrown.2013.2972">Tatton-Brown et al 2013</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p>23 were simplex cases with a <italic toggle="yes">de novo</italic> pathogenic variant.</p>
                </list-item>
                <list-item>
                  <p>14 were familial cases.</p>
                </list-item>
                <list-item>
                  <p>11 could not be confirmed as having a <italic toggle="yes">de novo</italic> or a familial pathogenic variant as parental testing was not performed or clinical information was not available from a parent.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are a <italic toggle="yes">de novo</italic> germline <italic toggle="yes">EZH2</italic> pathogenic variant in the proband or germline mosaicism in a parent (although no instances of germline mosaicism have been reported it remains a possibility).</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing is recommended for the parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Evaluation of parents may determine that one has a heterozygous germline <italic toggle="yes">EZH2</italic> pathogenic variant but has escaped previous diagnosis because of a milder phenotype. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</p>
            </list-item>
          </list>
          <p>Note: If the parent is the individual in whom the pathogenic variant first occurred, s/he may have somatic mosaicism for the variant and may be mildly/minimally affected.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband has a germline <italic toggle="yes">EZH2</italic> pathogenic variant, the risk to the sibs of inheriting the pathogenic variant is 50%. The phenotype of an individual inheriting the <italic toggle="yes">EZH2</italic> pathogenic variant cannot be predicted.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with <italic toggle="yes">EZH2</italic>-related overgrowth has a 50% chance of inheriting the <italic toggle="yes">EZH2</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents. If a parent has an <italic toggle="yes">EZH2</italic> pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="weaver.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, other possible non-medical explanations that could also be explored include alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="weaver.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the <italic toggle="yes">EZH2</italic> pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of this gene or custom prenatal testing.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> for <italic toggle="yes">EZH2</italic>-related overgrowth may be an option for some families in which the <italic toggle="yes">EZH2</italic> pathogenic variant has been identified.</p>
        </sec>
      </sec>
      <sec id="weaver.Resources">
        <title>Resources</title>
      </sec>
      <sec id="weaver.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> There are multiple alternative transcripts. The longest, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004456.4">NM_004456.4</ext-link>, comprises 20 exons. The first exon is non-coding. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="weaver" object-id="weaver.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> Factors to consider in the interpretation of sequence variants:</p>
        <list list-type="bullet">
          <list-item>
            <p>All d<italic toggle="yes">e novo</italic> germline missense and truncating variants in a simplex case (i.e., a single occurrence in a family) of Weaver syndrome are likely to be pathogenic.</p>
          </list-item>
          <list-item>
            <p>Inherited missense and truncating variants that segregate with the overgrowth phenotype are likely to be pathogenic.</p>
          </list-item>
          <list-item>
            <p>If parental samples are not available, missense and truncating variants should be interpreted with caution. Based on a small number of cases, current data (in which distribution of <italic toggle="yes">EZH2</italic> variants in cases vs controls, conservation of the SET domain (see <bold>Normal gene product</bold>) residues, and critical function of the SET domain in mediating histone methyltransferase activity were analyzed) suggest that SET domain missense variants are likely pathogenic. In addition, the few truncating variants that have been identified are all located in the final exon after the SET domain, although further studies are required to clarify the mechanism by which these variants cause overgrowth.</p>
          </list-item>
        </list>
        <table-wrap id="weaver.T.ezh2_pathogenic_variants_discus" position="anchor" orientation="portrait">
          <label>Table 2. </label>
          <caption>
            <p><italic toggle="yes">EZH2</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                <th id="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.458A&#x0003e;G</td>
                <td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr153Cys</td>
                <td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_3" rowspan="3" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004456.4">NM_004456.4</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_004447.2">NP_004447.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2044G&#x0003e;A</td>
                <td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala682Thr</td>
              </tr>
              <tr>
                <td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2233G&#x0003e;A</td>
                <td headers="hd_h_weaver.T.ezh2_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Glu745Lys</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> EZH2 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_004447.2">NP_004447.2</ext-link>), encoded by the longest transcript, is a 751-amino acid histone methyltransferase with a critical SET (su(var)3-9, enhancer of zeste, trithorax) domain, a pre-SET CXC domain, and two additional SANT (Sw13, Ada2, N-cor TFIIIB) domains [<xref ref-type="bibr" rid="weaver.REF.wu.2013.e83737">Wu et al 2013</xref>]. In combination with SUZ12 and EED (to form the polycomb repressor complex 2 [PCR2]), EZH2 acts to repress transcription through the methylation of lysine residue 27 of histone 3, a function catalyzed by the SET domain [<xref ref-type="bibr" rid="weaver.REF.cao.2002.1039">Cao et al 2002</xref>].</p>
        <p><bold>Abnormal gene product.</bold> The protein alterations and the mechanism by which <italic toggle="yes">EZH2</italic> missense and truncating variants cause Weaver syndrome are currently unknown. It is, however, noteworthy that pathogenic missense variants are the primary mutational mechanism; the few pathogenic truncating variants identified to date target the final exon, and thus are likely to be escaping nonsense-mediated RNA decay. Haploinsufficiency therefore seems an unlikely mechanism of generation of the <italic toggle="yes">EZH2-</italic>related Weaver syndrome phenotype.</p>
        <p><bold>Cancer.</bold> Somatic activating and inactivating mono- and biallelic <italic toggle="yes">EZH2</italic> pathogenic variants have been identified in various hematopoietic malignancies. Of particular note, a recurrent activating pathogenic variant targeting the Tyr646 residue has been identified in lymphomas, particularly large cell B-cell lymphomas and follicular lymphomas; inactivating pathogenic variants throughout the gene are identified in myelodysplastic and myeloproliferative neoplasms with a poor prognosis [<xref ref-type="bibr" rid="weaver.REF.morin.2010.181">Morin et al 2010</xref>, <xref ref-type="bibr" rid="weaver.REF.sneeringer.2010.20980">Sneeringer et al 2010</xref>, <xref ref-type="bibr" rid="weaver.REF.chase.2011.2613">Chase &#x00026; Cross 2011</xref>].</p>
        <p>Despite the association between somatic inactivating <italic toggle="yes">EZH2</italic> pathogenic variants and older-onset, chronic myeloproliferative/dysplastic syndromes, these malignancies have not been reported in individuals with <italic toggle="yes">EZH2-</italic>related overgrowth. Possible explanations for this finding:</p>
        <list list-type="bullet">
          <list-item>
            <p>Myeloproliferative/dysplastic syndromes usually occur at ages older than the age of most individuals currently identified with a germline (constitutional) <italic toggle="yes">EZH2</italic> pathogenic variant.</p>
          </list-item>
          <list-item>
            <p>The mechanisms by which <italic toggle="yes">EZH2</italic> somatic pathogenic variants cause malignancy and <italic toggle="yes">EZH2</italic> germline pathogenic variants cause overgrowth differ.</p>
          </list-item>
          <list-item>
            <p>Relatively few individuals with <italic toggle="yes">EZH2</italic> germline pathogenic variants have been identified to date.</p>
          </list-item>
        </list>
      </sec>
      <sec id="weaver.References">
        <title>References</title>
        <sec id="weaver.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="weaver.Literature_Cited.reflist0">
            <ref id="weaver.REF.alsalem.2013.225">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Salem</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alshammari</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alazami</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alkuraya</surname>
                    <given-names>FS</given-names>
                  </name>
                </person-group>
                <article-title>Weaver syndrome and defective cortical development: a rare association.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2013</year>
                <volume>161A</volume>
                <fpage>225</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23239504</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.cao.2002.1039">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erdjument-Bromage</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tempst</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Role of histone H3 lysine 27 methylation in Polycomb-group silencing.</article-title>
                <source>Science</source>
                <volume>298</volume>
                <fpage>1039</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">12351676</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.chase.2011.2613">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chase</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cross</surname>
                    <given-names>NC</given-names>
                  </name>
                </person-group>
                <article-title>Aberrations of EZH2 in cancer.</article-title>
                <source>Clin Cancer Res.</source>
                <year>2011</year>
                <volume>17</volume>
                <fpage>2613</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21367748</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.choufani.2010.343">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Choufani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shuman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weksberg</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Beckwith-Wiedemann syndrome.</article-title>
                <source>Am J Med Genet C Semin Med Genet</source>
                <volume>154C</volume>
                <fpage>343</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">20803657</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.douglas.2003.132">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Douglas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Upadhyaya</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomkins</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2003</year>
                <volume>72</volume>
                <fpage>132</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">12464997</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.gibson.2012.110">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>WT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hood</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhan</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bulman</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fejes</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mungall</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eydoux</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babul-Hirji</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>An</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marra</surname>
                    <given-names>MA</given-names>
                  </name>
                  <collab>FORGE Canada Consortium</collab>
                </person-group>
                <article-title>Chitayat D, Boycott KM, Weaver DD, Jones SJ. Mutations in EZH2 cause Weaver syndrome.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2012</year>
                <volume>90</volume>
                <fpage>110</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22177091</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.golabi.1984.345">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Golabi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>L.</given-names>
                  </name>
                </person-group>
                <article-title>A new X-linked mental retardation-overgrowth syndrome.</article-title>
                <source>Am J Med Genet.</source>
                <year>1984</year>
                <volume>17</volume>
                <fpage>345</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">6538755</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.klaassens.2015.610">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klaassens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morrogh</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosser</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaffer</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vreeburg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bok</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segboer</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Belzen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinlivan</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurst</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <article-title>Malan syndrome: Sotos-like overgrowth with de novo NFIX sequence variants and deletions in six new patients and a review of the literature.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2015</year>
                <volume>23</volume>
                <fpage>610</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">25118028</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.loeys.2010.476">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Loeys</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dietz</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braverman</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Callewaert</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Backer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devereux</surname>
                    <given-names>RB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hilhorst-Hofstee</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jondeau</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milewicz</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pyeritz</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sponseller</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wordsworth</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Paepe</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>The revised Ghent nosology for the Marfan syndrome.</article-title>
                <source>J Med Genet</source>
                <volume>47</volume>
                <fpage>476</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">20591885</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.malan.2010.189">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Malan</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajan</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Louis Dit Picard</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Layet</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Till</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Haeringen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nampoothiri</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puseljic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legeai-Mallet</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colleaux</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome.</article-title>
                <source>Am J Hum Genet</source>
                <volume>87</volume>
                <fpage>189</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">20673863</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.morin.2010.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Morin</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Severson</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mungall</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>An</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goya</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paul</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyle</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woolcock</surname>
                    <given-names>BW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuchenbauer</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yap</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Humphries</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffith</surname>
                    <given-names>OL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimbara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shashkin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charlot</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tcherpakov</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corbett</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tam</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varhol</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smailus</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moksa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delaney</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Qian</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birol</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schein</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horsman</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Connors</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aparicio</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirst</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gascoyne</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marra</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.</article-title>
                <source>Nat Genet</source>
                <volume>42</volume>
                <fpage>181</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20081860</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.schanze.2014.1092">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schanze</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neubauer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delrue</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dieux-Coeslier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holmberg</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koenig</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krueger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schanze</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seemanova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volleth</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meinecke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hennekam</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zenker</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Deletions in the 3' part of the NFIX gene including a recurrent Alu-mediated deletion of exon 6 and 7 account for previously unexplained cases of Marshall-Smith syndrome.</article-title>
                <source>Hum Mutat.</source>
                <year>2014</year>
                <volume>35</volume>
                <fpage>1092</fpage>
                <lpage>100</lpage>
                <pub-id pub-id-type="pmid">24924640</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.sneeringer.2010.20980">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sneeringer</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuntz</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knutson</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollock</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richon</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copeland</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>107</volume>
                <fpage>20980</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21078963</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.tattonbrown.2005.193">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tatton-Brown</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douglas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coleman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baujat</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Das</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horn</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faravelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waggoner</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turkmen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Irrthum</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations.</article-title>
                <source>Am J Hum Genet</source>
                <volume>77</volume>
                <fpage>193</fpage>
                <lpage>204</lpage>
                <pub-id pub-id-type="pmid">15942875</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.tattonbrown.2011.1127">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tatton-Brown</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruark</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zachariou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duarte Sdel</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramsay</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snape</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perdeaux</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loveday</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clericuzio</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flinter</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magee</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McConnell</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raith</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rankin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Splitt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strenger</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wheeler</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>KI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douglas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahman</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height.</article-title>
                <source>Oncotarget</source>
                <year>2011</year>
                <volume>2</volume>
                <fpage>1127</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">22190405</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.tattonbrown.2013.2972">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tatton-Brown</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murray</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douglas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clericuzio</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cushing</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flinter</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacquemont</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joss</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kinning</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magee</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McConnell</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medeira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozono</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rankin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shears</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Splitt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strenger</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stuurman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Titheradge</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seal</surname>
                    <given-names>S</given-names>
                  </name>
                  <collab>Childhood Overgrowth Consortium</collab>
                </person-group>
                <article-title>Rahman N. Weaver syndrome and EZH2 mutations: Clarifying the clinical phenotype.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2013</year>
                <volume>161A</volume>
                <fpage>2972</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">24214728</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.tattonbrown.2014.385">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tatton-Brown</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruark</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harmer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramsay</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Vecchio Duarte</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zachariou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aksglaede</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baralle</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dabir</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gener</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goudie</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Homfray</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilz</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selicorni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Temple</surname>
                    <given-names>IK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yachelevich</surname>
                    <given-names>N</given-names>
                  </name>
                  <collab>Childhood Overgrowth Consortium</collab>
                </person-group>
                <article-title>van Montfort R, Rahman N. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability.</article-title>
                <source>Nat Genet.</source>
                <year>2014</year>
                <volume>46</volume>
                <fpage>385</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24614070</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.tun_bilek.2006.20">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tun&#x000e7;bilek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alanay</surname>
                    <given-names>Y.</given-names>
                  </name>
                </person-group>
                <article-title>Congenital contractural arachnodactyly (Beals syndrome).</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2006</year>
                <volume>1</volume>
                <fpage>20</fpage>
                <pub-id pub-id-type="pmid">16740166</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.weaver.1974.547">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weaver</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>IT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <year>1974</year>
                <article-title>A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly.</article-title>
                <source>J Pediatr</source>
                <volume>84</volume>
                <fpage>547</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">4366187</pub-id>
              </element-citation>
            </ref>
            <ref id="weaver.REF.wu.2013.e83737">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeng</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senisterra</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seitova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vedadi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arrowsmith</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schapira</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Structure of the catalytic domain of EZH2 reveals conformational plasticity in cofactor and substrate binding sites and explains oncogenic mutations.</article-title>
                <source>PLoS One.</source>
                <volume>8</volume>
                <fpage>e83737</fpage>
                <pub-id pub-id-type="pmid">24367611</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="weaver.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="weaver.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>6 August 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>18 July 2013 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>23 January 2013 (ktb) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="weaver.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Retrognathia present in younger children with <italic toggle="yes">EZH2</italic>-related Weaver syndrome usually resolves with age. In individuals of all ages the palpebral fissures are frequently almond-shaped and the eyes are widely spaced.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="weaver-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="weaver.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Mild hyperextension of the distal interphalangeal joints and flexion of the proximal interphalangeal joints in a woman age 22 years with a heterozygous <italic toggle="yes">EZH2</italic> pathogenic variant</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="weaver-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
